Masuda, Ken
Horinouchi, Hidehito http://orcid.org/0000-0001-9090-801X
Tanaka, Midori
Higashiyama, Ryoko
Shinno, Yuki
Sato, Jun
Matsumoto, Yuji
Okuma, Yusuke
Yoshida, Tatsuya
Goto, Yasushi
Yamamoto, Noboru
Ohe, Yuichiro
Article History
Received: 8 June 2020
Accepted: 18 July 2020
First Online: 23 July 2020
Compliance with ethical standards
:
: Dr. Ohe reports grants and personal fees from Ono Pharmaceutical, grants and personal fees from Bristol-Myers Squibb, grants and personal fees from MSD, during the conduct of the study; grants and personal fees from AstraZeneca, personal fees from Boehringer Ingelheim, grants and personal fees from Chugai, grants and personal fees from Eli Lilly, grants and personal fees from Taiho, grants and personal fees from Takeda, grants and personal fees from Nippon Kayaku, grants and personal fees from Kyorin, grants and personal fees from Novartis, grants and personal fees from Janssen, personal fees from Pfizer, grants from Ignyta, grants from Kyowa Hakko Kirin, personal fees from Celtrion, personal fees from Amgen. Dr. Yamamoto reports grants from Chugai, grants from Taiho, grants from Eisai, grants from Lilly, grants from Quintiles, grants from Astellas, grants from BMS, grants from Novartis, grants from Daiichi-Sankyo, grants from Pfizer, grants from Boehringer Ingelheim, grants from Kyowa-Hakko Kirin, grants from Bayer, grants from ONO PHARMACEUTICAL CO., LTD, grants from Takeda, personal fees from ONO PHARMACEUTICAL CO., LTD, personal fees from Chugai, personal fees from AstraZeneca, personal fees from Pfizer, personal fees from Lilly, personal fees from BMS, personal fees from Eisai, personal fees from Otsuka, personal fees from Takeda, personal fees from Boehringer Ingelheim, personal fees from Cimic, grants from Janssen Pharma, grants from MSD, grants from Merck, personal fees from Sysmex, grants from GSK. Dr. Goto reports grants and personal fees from Eli Lilly, grants and personal fees from Chugai, grants and personal fees from Taiho Pharmaceutical, personal fees from Boehringer Ingelheim, grants and personal fees from Pfizer, grants and personal fees from Novartis, personal fees from AstraZeneca, grants and personal fees from MSD, grants and personal fees from Guardant Health, grants and personal fees from Ono Pharmaceutical, grants from Kyorin, grants from Dai-ichi Sankyo, personal fees from Illumina. Dr. Yoshida reports grants from MSD, grants from Ono Pharmaceutical, grants from Bristol-Myers Squibb, during the conduct of the study; grants and personal fees from AstraZeneca, grants from Takeda, personal fees from Chugai, personal fees from Novartis, and personal fees from Abbvie. Dr. Okuma reports personal fees from AstraZeneca, personal fees from Boehringer Ingelheim, personal fees from Chugai, personal fees from Ono, personal fees from Ily Lilly, personal fees from Bristol Myers Squibb. Dr. Matsumoto reports grants from Hitachi, Ltd., grants from Hitachi High-Technologies, personal fees from Olympus, personal fees from AstraZeneca, personal fees from Novartis, and personal fees from COOK. Dr. Horinouchi reports grants and personal fees from BMS, grants and personal fees from MSD, grants and personal fees from Chugai, grants and personal fees from Taiho, grants and personal fees from Astra Zeneca, grants from Astellas, grants from Merck Serono, grants from Genomic Health, grants and personal fees from Lilly, grants and personal fees from Ono. The remaining authors declare no conflict of interest.
: The study was approved by the Institutional Review Board of the National Cancer Center Hospital (No. 2015–355).
: This manuscript contains no individual person’s data.